The FDA's top drug regulator, Dr. George Tidmarsh, quit after federal officials began reviewing "serious concerns about his personal conduct," a government spokesperson said.
For Indian pharmaceutical companies that already supply nearly half of all generic medicines sold in the US, the decision ...
Legal framework, Localization, Public Health Law, Saudi Arabia, Vaccine Manufacturing, Vision 2030 Share and Cite: Alshammari ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback